Coccidioidomycosis in Patients Treated with Ruxolitinib

9Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.

Cite

CITATION STYLE

APA

Kusne, Y., Kimes, K. E., Feller, F. F., Patron, R., Banacloche, J. G., Blair, J. E., … Ampel, N. M. (2020). Coccidioidomycosis in Patients Treated with Ruxolitinib. Open Forum Infectious Diseases, 7(6). https://doi.org/10.1093/ofid/ofaa167

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free